SCHEMBL5170673

SCHEMBL5170673

CCn1ccnc1OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
VDR P11473 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 2/20 0.37
DHODH Q02127 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5172102 0.89 KDM4E (0.40) KEAP1NFE2L2VDRKDM4EALDH1A1
SCHEMBL2457496 0.87 METAP2 (0.40) SMN1; SMN2KDM4EALDH1A1MEN1GAA
SCHEMBL1885705 0.87 ALDH1A1 (0.47) SMN1; SMN2KEAP1NFE2L2VDRKDM4E
SCHEMBL1889711 0.81 KDM4E (0.47) SMN1; SMN2KEAP1NFE2L2VDRKDM4E
SCHEMBL9309185 0.79 KEAP1 (0.41) SMN1; SMN2KEAP1NFE2L2VDRKDM4E
SCHEMBL1681964 0.77 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1KMT2A
SCHEMBL2276316 0.74 ADRA2A (0.42) KDM4EALDH1A1MEN1GAAKMT2A
SCHEMBL2394920 0.72 ALDH1A1 (0.48) SMN1; SMN2KDM4EALDH1A1MEN1GAA
SCHEMBL8211578 0.70 ALDH1A1 (0.44) SMN1; SMN2KDM4EALDH1A1GAAKMT2A
SCHEMBL30564825 0.70 ALDH1A1 (0.47) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663921-B1 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AG (DE) 2007-05-02 EP claimed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US claimed
CN-111836849-B Process for producing fibers, films and moldings of polybenzazole polymer (P) 巴斯夫欧洲公司 2023-04-07 CN disclosed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP disclosed
EP-3762447-A1 METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2021-01-13 EP disclosed
US-20200407508-A1 METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2020-12-31 US disclosed
WO-2019170529-A1 METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2019-09-12 WO disclosed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070055084-A1 Method for producing haloalkanes from alcohols ADH1C, HDHD5, ADH5 SMN1; SMN2 4795/4885KEAP1 1890/4885NFE2L2 3088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.